»ï¼º¼¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22±³À°ÀÏÀÚ : 2022-10-22
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2022 Samsung-Mayo Clinic Heart SymposiumÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼øȯ±â³»°ú
´ã´çÀÚ : ÀåÇý¼÷
¿¬¶ôó : 02-3410-3792
À̸ÞÀÏ :
hs0129.jang@samsung.com ±³À°Á¾·ù : ³»°ú±âŸ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 08:45~09:00 Pathophysiology of HFpEF Omar F. Abou Ezzeddine(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:00~09:15 Cardiac Amyloidosis: diagnostic challenge ±è´Ù·¡(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:15~09:30 Coronary microvascular dysfunction in HFpEF ÃÖ±âÈ«(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:30~09:45 Excersise stress test in HFpEF Jae K. Oh(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:45~10:00 Promising treatment candidates in HFpEF Atta Behfar(Mayo Clinic, USA)
Åä·Ð 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:00~10:30 Discussion ()
ÈÞ½Ä 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:30~10:45 Coffee break ()
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:45~11:00 Acute RV failure : assessment and management with critical care medicine À强¾Æ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:00~11:15 New tools to prevent SCD: the Extravascular ICD Paul A. Friedman(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:15~11:30 Diagnostic conundrums in HFrEF: My tip and tricks Omar F. Abou Ezzeddine(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:30~11:45 Latest update on new medical treatment in HFrEF ÃÖÁø¿À(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:45~12:00 Revascularization strategy in ischemic cardiomyopathy: CABG PCI OMT ÀÌÁÖ¸í(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 12:00~12:15 From Silicone to Clinical Trials and Bedside to Home: AI to predict and detect ventricular dysfunction. Paul A. Friedman(Mayo Clinic, USA)
Åä·Ð 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 12:15~12:45 Discussion ()
½Ä»ç 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 12:45~13:30 Lunch ()
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:30~13:45 CRT in NYHA IV patients on inotropes ¹Ú½ÂÁ¤(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:45~14:00 TAVR in congestive heart failure Mayra Guerrero(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:00~14:15 Percutaneous intervention for severe MR and TR Mayra Guerrero(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:15~14:30 Optimal weaning strategy in VA ECMO ¾çÁ¤ÈÆ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:30~14:45 Optimal maintenance therapy after LVAD implantation Atta Behfar(Mayo Clinic, USA)
Åä·Ð 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:45~15:15 Discussion ()
ÈÞ½Ä 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:15~15:30 Coffee break ()
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:30~15:45 Artificial Intelligence Basics: What the Clinician needs to know. ±èÁÖ¿¬(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:45~16:00 Current status of Echo AI Jae K. Oh(Mayo Clinic, USA)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:00~16:15 Current status of Hemodynamic monitoring AI ±ÇÁظí(¸ÞµðÄÿ¡À̾ÆÀÌ/¼¼Á¾º´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:15~16:30 Machine Learning to Assist Accurate Clinical Decision in valvular heart disease À̽ÂÇ¥(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-22 »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:30~16:45 AI to Find Hidden Atrial Fibrillation: State of the Art Paul A. Friedman(Mayo Clinic, USA)
Åä·Ð 10-22 16:45~17:15 Discussion ()